REQUIREMENTS FOR IDENTIFICATION OF LOW DOSE AND NON-LINEAR MUTAGENIC RESPONSES TO IONISING RADIATION by Sykes, Pamela J & Day, Tanya K
Dose-Response: An International Journal
Volume 5





OF LOW DOSE AND NON-LINEAR
MUTAGENIC RESPONSES TO IONISING
RADIATION
Pamela J Sykes
Flinders University and Medical Centre, Bedford Park, South Australia, Australia
Tanya K Day
Flinders University and Medical Centre, Bedford Park, South Australia, Australia
Follow this and additional works at: https://scholarworks.umass.edu/dose_response
This Article is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in Dose-Response: An
International Journal by an authorized editor of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.
Recommended Citation
Sykes, Pamela J and Day, Tanya K (2007) "REQUIREMENTS FOR IDENTIFICATION OF LOW DOSE AND NON-LINEAR
MUTAGENIC RESPONSES TO IONISING RADIATION," Dose-Response: An International Journal: Vol. 5 : Iss. 4 , Article 9.
Available at: https://scholarworks.umass.edu/dose_response/vol5/iss4/9
Dose-Response 5: 308–314, 2007
Formerly Nonlinearity in Biology, Toxicology, and Medicine




REQUIREMENTS FOR IDENTIFICATION OF LOW DOSE AND NON-LINEAR
MUTAGENIC RESPONSES TO IONISING RADIATION
Pamela J. Sykes and Tanya K. Day  Department of Haematology and Genetic
Pathology, Flinders University and Medical Centre, Bedford Park, South Australia,
Australia
 Cancer results from multiple changes in gene expression that can occur both geneti-
cally and epigenetically. High doses of radiation can lead to mutations and cancer. At high
doses the number of mutations caused by radiation is essentially linear with dose. Low
dose radiation induced protective responses observed for cancer in vivo and cellular trans-
formation in vitro would predict that hormetic responses would also be observed in muta-
tion assays. Although there are a large number of different mutation assays available, very
few are able to detect changes in mutation frequency in response to very low doses of DNA
damaging agents. The easiest way to cope with this lack of data in the low dose range is to
invoke a linear-no-threshold model for risk assessment. The reasons for the lack of data
are discussed. In order to identify hormetic mutation responses, assays need to have a
spontaneous frequency that is high enough to enable a reduction below spontaneous fre-
quency to be detected in a feasible number of scored cells and also need to be able to iden-
tify both genetic and epigenetic changes. The pKZ1 chromosomal inversion assay fits the
criteria for detecting hormetic responses to low dose radiation. 
Keywords: pKZ1 inversion assay, chromosomal inversion, low dose ionising radiation, mutation
assays, hormesis
INTRODUCTION
High doses of radiation can lead to mutations and an accumulation of
mutations can lead to cancer. There is evidence from epidemiological
studies that doses of radiation above 100 mSv cause cancer. However, epi-
demiological studies have not been able to provide convincing evidence
for increased cancer risk for effective doses of a few tens of mSv per year
above the background level of exposure. At very low doses it is not possi-
ble to perform classical epidemiology studies because of the very large
number of people that would need to be included in such studies, the
high frequency of cancer in the general population, the difficulty of meas-
uring the true individual radiation exposure and identification of life-style
and genetic confounders. In mouse studies, radiation doses and exposure
conditions, together with diet and environmental conditions, can be pre-
cisely controlled., However the number of mice required to determine
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altered cancer risk at doses as low as, for example 1 mSv, can be in the mil-
lions. Such studies are both logistically and economically unfeasible.
Presently risk assessment for radiation exposure is based on the linear
no-threshold (LNT) hypothesis that predicts that even the smallest amount
of radiation increases cancer risk. The related phenomena of adaptive
response, bystander effects and genomic instability all suggest that the LNT
model is not accurate for low dose radiation exposure (reviewed in Morgan
(2003)). There are studies that have shown that low doses of radiation may
be protective. Increased survival of normal and cancer prone animals has
been described after low dose radiation exposure, either as a low dose
alone or prior to a subsequent high radiation dose (Mitchel et al, 1999;
2003; Ina et al, 2005). Transformation assays have been used for some time
as a surrogate marker for tumorigenic potential, and similar protective
effects have been identified (Azzam et al, 1996; Redpath et al, 2003).
However, transformation assays are performed in vitro and may not be
indicative of the effect that is occurring post-irradiation in a whole animal.
In vivo changes in mutation frequency after radiation exposure reflect DNA
changes and can also act as a surrogate marker for tumorigenic potential.
At high doses the number of mutations caused by radiation essentially fol-
lows a linear response. After extremely high doses of radiation the cell will
die. However, as the radiation dose decreases there is a chance that the cell
will survive either with radiation damage that has been fully repaired or
radiation damage that has not been repaired correctly resulting in some
mutations that are passed on to daughter cells. If those daughter cells con-
tinue to accumulate mutations then a cancer may result. Many mutation
studies have been performed in vitro or after in vivo exposure to provide a
surrogate measure for carcinogenesis and also for monitoring of radiation
damage. Although there are a large number of mutation assays available,
very few are able to detect a change in mutation frequency after very low
doses of DNA damaging agents. The protective effects observed in tumour
and transformation assays after low dose radiation exposure are examples
of a hormetic response. Given the close relationship between mutation fre-
quency and cancer it is expected that such protective effects should be
accompanied by a reduction in mutation frequency. However, there is a
paucity of data in the literature demonstrating a reduction to below the
spontaneous mutation frequency after low dose radiation. Such protective
effects may be happening but it is unlikely that they will be observed using
the majority of popularly used mutation assay systems, largely because most
mutagenic studies that have been performed for low doses of agents have
not conformed to the criteria required for detection of hormetic respons-
es. Calabrese and Baldwin (2001) have defined the general requirements
in order to be able to detect a hormetic type response for biological end-
points of any type. The criteria are equally valid for mutation studies. The
a priori study criteria include the need for:
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• A well-defined NOAEL (no observed adverse effect)
• At least 2 doses below the NOAEL and at least one dose above the
NOAEL
• The assay to have the capacity to display a stimulatory and an inhibito-
ry response.
• Analyses that cover doses ranging over 3-4 orders of magnitude.
• Determination of the appropriate time of analysis as the responses can
vary with time (Calabrese and Baldwin, 2002). 
The criteria related to study design can be managed reasonably easi-
ly, but there are few mutation assays capable of feasibly detecting both
stimulatory and inhibitory responses. We have demonstrated that the in
vivo pKZ1 transgenic mouse assay is a very sensitive assay for detection of
chromosomal inversions in response to extremely low doses of X-radia-
tion exposure. Here we describe the reasons why the pKZ1 assay is so sen-
sitive and why it is capable of detecting both stimulatory and inhibitory
responses, compared with other currently used mutation assays.
SENSITIVITY OF MUTATION ASSAYS TO RADIATION EXPOSURE
The lowest doses at which alterations in chromosomal aberrations
and mutations have been detected in mammalian experimental systems
exposed to acute low LET radiation are outlined in Table 1. In mam-
malian cells the lowest dose causing an increase in mutations was 10 mGy
(Schiestl et al, 1994). Using the γ-H2AX assay in mammalian cell lines,
Rothkamm and Lobrich (2003) demonstrated that this assay could be
used to detect double strand DNA breaks in response to doses as low as 1
mGy X-radiation.
Most mutation assays are performed in vitro because of the ease of
artificial selection systems for mutant detection and lower cost than in
vivo studies. The most commonly used assays have included chromosome
aberrations in metaphase spreads, the micronucleus assay, the HPRT
assay, and the comet assay. In vivo assays include analysis of blood samples
TABLE 1. Lowest doses at which chromosomal aberrations and mutations have been detected in
experimental systems in mammalian cells exposed to acute low-LET radiation exposure 
System Endpoint Radiation Lowest dose Reference
(mGy)
Human Unstable chromosomal X-rays 20 Lloyd et al (1992)
lymphocytes aberrations
Human Stable chromosomal Gamma rays 250 Lloyd (1998)
lymphocytes aberrations
Mouse Pink-eye mutation X-rays 10 Schiestl et al (1994)
TK6 cells Hprt and tk mutation X-rays 250 Konig and Kiefer (1988)
adapted from Sources and Effects of Ionising Radiation 2000 UNSCEAR report, Vol II
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from animals, animal models harbouring mutations that enable a method
of mutant selection such as the mouse pink-eye model, or transgenic ani-
mals with artificial selection systems. In almost all cases, the studies using
these assays have been performed at doses greater than 100 mGy, doses
which are not relevant to a likely human exposure in an occupational or
public exposure situation.
The pKZ1 in vivo assay is a transgenic mouse assay. The transgene is
comprised of an E. coli lacZ gene in an inverse transcriptional orientation
relative to a chicken β-actin enhancer-promoter (EP) complex. Inversions
in the transgene are facilitated by mouse recombination signal sequences
flanking the lacZ gene, placing the lacZ gene in the correct transcription-
al orientation to the EP complex, resulting in expression of the lacZ gene
product, β-galactosidase (β-gal). The E.coli β-gal can then be detected his-
tochemically in tissue sections using the chromogenic substrate, X-gal
(Sykes et al, 1998). Using the pKZ1 assay we have demonstrated a statisti-
cally significant induction of chromosomal inversions after a single X-
radiation dose of 5 μGy in both spleen and prostate (Hooker et al. 2004;
Zeng et al. 2006), lowering the dose range of observable mutagenic radi-
ation effects by three orders of magnitude. 
SPONTANEOUS MUTATION FREQUENCY
A number of mutation assays have demonstrated that a low dose of
radiation can result in the production of responses that can protect
against the induction of a portion of mutations from a subsequent high
dose exposure. However, using these same assays, no significant response
has been observed after exposure to a single low radiation dose.
Therefore the mutation assays are capable of detecting the effects of low
doses of radiation but the number of mutant events that are scored are
too low to detect after low doses of radiation exposure. Cancer studies
that have shown that a low dose of radiation can result in fewer cancers
compared to animals that did not receive radiation also suggest that in
these cases fewer mutations are occurring in the treated animals than in
the untreated animals. Historically, investigators have strived to ensure
low spontaneous frequencies in mutation assays in order to detect rare
events after DNA damaging agent exposure. If the spontaneous frequen-
cy were higher in these assays, then a larger number of induced muta-
tions would need to be detected in order to see a statistically significant
increase in mutations. In order to determine if there are less mutations
occurring compared with the normal spontaneous mutation frequency,
mutation assays must be capable of detecting mutation frequencies below
the normal spontaneous mutation frequency. This is extremely difficult
with a large number of mutation assays as the spontaneous frequency is
of the order of 10–5 – 10–6. In order to detect a mutation frequency below
4
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these spontaneous frequencies with any statistical confidence, a very large
number of cells would need to be screened. The feasibility of doing such
studies is low for logistical reasons. Assays with higher spontaneous fre-
quencies enable feasible detection below spontaneous frequencies. The
commonly used cytokinesis-block micronucleus assay has a high sponta-
neous frequency (approximately 5 × 10–2) and should therefore be capa-
ble of detecting a reduction below spontaneous frequency. The sponta-
neous inversion frequency in pKZ1 spleen cells is approx 10–4 and in
pKZ1 prostate luminal epithelial cells is 3 × 10–3. Using the pKZ1 assay we
have demonstrated a statistically significant reduction to below sponta-
neous frequency in spleen (by analysing 2 × 105 cells) and prostate tissue
(by analysing 6 × 103 cells) after a single acute X-radiation exposure of 1
or 10 mGy (Hooker et al, 2004, Zeng et al, 2006). High spontaneous muta-
tion frequencies allow detection of a reduction in inversion frequency
below the spontaneous frequency without the need to count a prohibitive
number of cells. 
MEASUREMENT OF DIRECT AND INDIRECT DNA DAMAGE
Mutation assays detect the response to DNA damage, either as DNA
damage itself, which may or may not have been the initial lesion, or the
result of repair of the DNA damage. It is usually assumed that the initial
DNA damage that was produced by the DNA damaging agent occurs in
the region of DNA that is analysed as the endpoint of the mutation assay.
The dose of radiation administered to an organism enables estimates of
the number of ionisation tracks deposited in individual cells. At extreme-
ly low doses of radiation very few cells will sustain a direct hit. It is known
that cells do not need to sustain a direct hit in order to respond to radia-
tion. This phenomenon is called the bystander effect (reviewed in
Mothersill and Seymour, 2005). The signals that pass from the hit cell to
the unhit bystander cell are likely to cause many effects, including muta-
tions or protection from mutations. These mutations are not caused
directly by the radiation and may involve epigenetic intermediates.
Therefore, in order to detect a protective effect against mutations from
low dose radiation, a sensitive assay is required which has both a high
spontaneous frequency and the ability to respond to bystander signals. At
doses of 1 mGy or less the bystander effect is playing a role as not all cells
will receive an energy deposition (Bond et al, 1988). It is hypothesised
that the chromosomal inversion in the pKZ1 transgene occurs as a result
of the formation of a stem and loop structure, which is subsequently
recognised by recombination enzymes that resolve the stem and loop
structure into an inversion. Therefore any biological response to radia-
tion exposure, either in a cell that is directly hit by radiation or any
bystander cells, which affects chromatin structure or recombination
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enzyme activity on stem and loop structures could be detected as a
change in the inversion frequency. Although the radiation dose may be
small, the overall biological response to the low dose might be quite large,
which would explain the high sensitivity of the pKZ1 assay. 
CONCLUSION
The paucity of hormetic responses for mutation end-points in the
radiation literature is possibly due to the technical difficulty of detecting
such responses in the majority of mutation assays. Mutation assays with
the ability to detect both stimulatory and inhibitory responses are
required. Detection of a reduction below spontaneous mutation fre-
quency will be largely dependent on a relatively high spontaneous fre-
quency. The overall sensitivity of the mutation assay is also likely to be
dependent on the assay being capable of detecting bystander responses.
It is also preferable that the assays be in vivo assays in order to incorpo-
rate normal metabolic and physiological processes. The pKZ1 in vivo
assay fits all of these criteria. Even so, hormetic responses will only be
detected with such an assay if the experimental design spans dose ranges
that fit the a priori criteria for detection of hormetic responses (Calabrese
and Baldwin, 2001).
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